Invention Grant
- Patent Title: Sodium alginate crosslinked slow-release moxifloxacin microsphere, the preparation method and the use thereof, and target vascular occlusive agent of the microsphere
- Patent Title (中): 海藻酸钠交联缓释莫西沙星微球体,其制备方法及其应用,以及微球靶向血管闭塞剂
-
Application No.: US13809361Application Date: 2010-12-30
-
Publication No.: US09028847B2Publication Date: 2015-05-12
- Inventor: Xinjian Li , Hong Hong
- Applicant: Xinjian Li , Hong Hong
- Applicant Address: CN Beijing
- Assignee: Beijing Shengyiyao Technology & Development Co., Ltd.
- Current Assignee: Beijing Shengyiyao Technology & Development Co., Ltd.
- Current Assignee Address: CN Beijing
- Agency: Christie, Parker & Hale, LLP
- Priority: CN201010222446 20100709
- International Application: PCT/CN2010/080549 WO 20101230
- International Announcement: WO2012/003704 WO 20120112
- Main IPC: A61K9/16
- IPC: A61K9/16 ; A61K31/4709 ; C07D471/04

Abstract:
A sodium alginate crosslinked slow-released moxifloxacin microsphere, the preparation method of the microsphere, a vascular target embolus containing the microsphere and the use of the microsphere in preparing the vascular target embolus. The microsphere contains moxifloxacin, a drug carrier, a adsorbent, a reinforcing agent and a solidifying agent, wherein the drug carrier is sodium alginate, the adsorbent is albumin prepared from human plasma or bovine serum albumin, the reinforcing agent is gelatin or hyaluronic acid, and the solidifying agent is a divalent metal cation chosen from calcium salt or barium salt.
Public/Granted literature
Information query